CONMED (CNMD) - 2023 Q1 - Earnings Call Presentation

WE DO WE MAKE and keep commitments. with urgency. Updated Full-Year 2023 Financial Guidance •Increased full-year adjusted cash EPS guidance to $3.30 -$3.50, from the prior range of $3.20 –$3.45, which continues to include between $0.20 and$0.25 of FX headwind Warehouse Software Implementation Update • Exited 2022 with approximately $30M of WMS related shippable backlog • Focus is on continuing to regain volumes that were affected by the disruption. The ultimate impact remains unknown, however, orders wer ...